Search
Patexia Research
Case number 1:22-md-03038

In Re: Ozempic (Semaglutide) Patent Litigation > Documents

Date Field Doc. No.Description (Pages)
Dec 13, 2024 423 SO ORDERED, re (422 in 1:22-md-03038-CFC-EGT, 36 in 1:22-cv-00297-CFC, 371 in 1:22-cv-00294-CFC-EGT) Stipulation of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences, filed by Novo Nordisk A/S, Novo Nordisk Inc. (Terminating Hearings: 12/16/2024 Bench Trial terminated.) Signed by Judge Colm F. Connolly on 12/13/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC, 1:22-md-03038-CFC-EGT(kmd) (Entered: 12/13/2024) (3)
Dec 13, 2024 424 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): See attached. (Attachments: # 1 Stipulation of Dismissal) (mws) (Entered: 12/13/2024) (0)
Dec 12, 2024 422 STIPULATION of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences by Novo Nordisk Inc., Novo Nordisk A/S. (Egan, Brian) (Entered: 12/12/2024) (3)
Dec 6, 2024 420 MOTION for Limited Exemption from the Standing Order Regarding Personal Electronic Devices - filed by Novo Nordisk Inc., Novo Nordisk A/S. Motions referred to Eleanor G. Tennyson.(Murray, Travis) (Entered: 12/06/2024) (3)
Dec 6, 2024 421 SO ORDERED, re (369 in 1:22-cv-00294-CFC-EGT, 420 in 1:22-md-03038-CFC-EGT) MOTION for Limited Exemption from the Standing Order Regarding Personal Electronic Devices, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/6/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (kmd) (Entered: 12/06/2024) (3)
Dec 3, 2024 418 STIPULATION of Dismissal (as to Defendants Rio Biopharmaceuticals, Inc. and EMS S/A - without prejudice) by Novo Nordisk Inc., Novo Nordisk A/S. (Murray, Travis) (Entered: 12/03/2024) (3)
Dec 3, 2024 419 ORDER re (367 in 1:22-cv-00294-CFC-EGT, 418 in 1:22-md-03038-CFC-EGT) Stipulation of Dismissal (as to Defendants Rio Biopharmaceuticals, Inc. and EMS S/A - without prejudice). Party EMS S/A and Rio Biopharmaceuticals, Inc. terminated. Signed by Judge Colm F. Connolly on 12/3/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT(mws) (Entered: 12/03/2024) (3)
Nov 18, 2024 417 Official Transcript of Pretrial Conference held on 11/18/2024 before Judge Colm F. Connolly. Court Reporter/Transcriber Bonnie Archer. Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/9/2024. Redacted Transcript Deadline set for 12/19/2024. Release of Transcript Restriction set for 2/17/2025. (mws) (Entered: 11/18/2024) (26)
Nov 15, 2024 413 ORDER granting (361 in case 1:22-cv-00294-CFC-EGT; 411 in case 1:22-md-03038-CFC-EGT) MOTION for Exemption from the Standing Order Regarding Personal Electronic Devices. Signed by Judge Colm F. Connolly on 11/14/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (kmd) (Entered: 11/15/2024) (3)
Nov 15, 2024 414 ORAL ORDER: Defendants' motion for exemption of persons from the Court's standing order regarding electronic devices (D.I. 362 in 22-294, D.I. 412 in 22-md-3038) is DENIED. The motion asks that the Court exempt certain persons from the standing order but does not identify who the certain persons are. The motion intimates that the universe of certain persons may consist of only four individuals (two of whom the Court believes are Delaware lawyers who one would think meet the exemptions listed in paragraph 4 of the standing order), but the Court cant be sure that is the case. Finally, the motion does not identify what role if any these four individuals play in the case or why these four individuals need their phones during the pretrial conference. Ordered by Judge Colm F. Connolly on 11/15/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT(mws) (Entered: 11/15/2024) (0)
Nov 15, 2024 415 Amended MOTION For Exemption from May 17, 2024 Standing Order on Personal Devices - filed by Rio Biopharmaceuticals, Inc., EMS S/A. Motion no longer referred to Eleanor G. Tennyson.(Dorsney, Kenneth) (Entered: 11/15/2024) (3)
Nov 15, 2024 416 ORDER granting (365 in case 1:22-cv-00294-CFC-EGT; 415 in case 1:22-md-03038-CFC-EGT) Amended MOTION For Exemption from May 17, 2024 Standing Order on Personal Devices. Signed by Judge Colm F. Connolly on 11/15/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-md-03038-CFC-EGT (kmd) (Entered: 11/15/2024) (3)
Nov 14, 2024 411 MOTION for Exemption from the Standing Order Regarding Personal Electronic Devices - filed by Novo Nordisk Inc., Novo Nordisk A/S. Motions no longer referred to Eleanor G. Tennyson.(Murray, Travis) (Entered: 11/14/2024) (3)
Nov 14, 2024 412 MOTION For Exemption from May 17, 2024 Standing Order on Personal Devices - filed by Rio Biopharmaceuticals, Inc., EMS S/A. Motions no longer referred to Eleanor G. Tennyson.(Dorsney, Kenneth) (Entered: 11/14/2024) (3)
Nov 8, 2024 410 NOTICE OF SERVICE of Defendants' Joint Section 282 Notice filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 11/08/2024) (3)
Nov 5, 2024 409 ORDER: having reviewed the joint status report filed by the parties on October 31, 2024 (D.1. 406) and the Proposed Pretrial Order (D.I. 405), it is HEREBY ORDERED that Defendants' decision to "not include[] any invalidity theories against the [#]343 patent in the Proposed Joint Pretrial Order," D.I. 406 at 2, constitutes a waiver of their right to challenge the validity of the #343 patent at the trial scheduled to begin on December 9, 2024. Signed by Judge Colm F. Connolly on 11/5/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT(mws) (Entered: 11/05/2024) (2)
Nov 4, 2024 408 REDACTED VERSION of (355 in 1:22-cv-00294-CFC-EGT, 405 in 1:22-md-03038-CFC-EGT) Proposed Pretrial Order,,,, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 6A, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Murray, Travis) (Entered: 11/04/2024) (0)
Nov 1, 2024 407 REDACTED VERSION of (406 in 1:22-md-03038-CFC-EGT, 356 in 1:22-cv-00294-CFC-EGT) Status Report - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/01/2024) (3)
Oct 31, 2024 406 [SEALED] Joint STATUS REPORT - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/31/2024) (0)
Oct 28, 2024 404 SO ORDERED, re (403 in 1:22-md-03038-CFC-EGT, 353 in 1:22-cv-00294-CFC-EGT) Joint STIPULATION and [Proposed] Order Regarding Infringement of the '343 and '462 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 10/28/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (kmd) (Entered: 10/28/2024) (6)
Oct 28, 2024 405 [SEALED] Proposed Pretrial Order (Joint) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exhibit 1 - Statement of Uncontested Facts, # 2 Exhibit 2 - Plaintiffs' Statement of Issues of Fact, # 3 Exhibit 3 - Defendants' Statement of Issues of Fact, # 4 Exhibit 4 - Plaintiffs' Statement of Issues of Law, # 5 Exhibit 5 - Defendants' Statement of Issues of Law, # 6 Exhibit 6 - Plaintiffs' Witness List, # 7 Exhibit 6A - Plaintiffs' Expert Testimony, # 8 Exhibit 7 - Defendants' Witness List, # 9 Exhibit 8 - Deposition Designations, Counters, and Objs, # 10 Exhibit 9 - Joint Trial Exhibit List (JTX), # 11 Exhibit 10 - Plaintiffs' Trial Exhibit List (PTX), # 12 Exhibit 11 - Defendants' Trial Exhibit List (DTX), # 13 Exhibit 12 - Plaintiffs' Statement of Intended Proofs, # 14 Exhibit 13 - Defendants' Statement of Intended Proofs, # 15 Exhibit 14 - Plaintiffs' Motions in Limine (Nos. 2&3), # 16 Exhibit 15 - Plaintiffs' Statement of Additional Issues to be Resolved)(Murray, Travis) (Entered: 10/28/2024) (0)
Oct 25, 2024 403 Joint STIPULATION and [Proposed] Order Regarding Infringement of the '343 and '462 Patents by Rio Biopharmaceuticals Inc. and EMS S/A by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/25/2024) (6)
Oct 16, 2024 400 SO ORDERED, re (347 in 1:22-cv-00294-CFC-EGT, 397 in 1:22-md-03038-CFC-EGT, 25 in 1:22-cv-00296-CFC) Stipulation of Dismissal without prejudice as to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc., filed by Novo Nordisk A/S, Novo Nordisk Inc. Party Sun Pharmaceutical Industries Inc. and Sun Pharmaceutical Industries Ltd. terminated. Signed by Judge Colm F. Connolly on 10/16/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-00296-CFC (kmd) (Entered: 10/16/2024) (3)
Oct 16, 2024 401 SO ORDERED, re (348 in 1:22-cv-00294-CFC-EGT, 398 in 1:22-md-03038-CFC-EGT, 26 in 1:22-cv-00298-CFC) Stipulation of Dismissal filed by Novo Nordisk A/S, Novo Nordisk Inc. Party Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories Ltd. terminated. Signed by Judge Colm F. Connolly on 10/16/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-00298-CFC(mws) (Entered: 10/16/2024) (3)
Oct 16, 2024 402 SO ORDERED, re (399 in 1:22-md-03038, 349 in 1:22-cv-00294-CFC-EGT) STIPULATION and [Proposed] Order to Extend Close of Expert Discovery and Daubert Motion Deadlines; Reset Scheduling Order Deadlines: ( Expert Discovery due by 10/16/2024). Signed by Judge Colm F. Connolly on 10/16/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (mws) (Entered: 10/17/2024) (4)
Oct 9, 2024 399 STIPULATION and [Proposed] Order to Extend Close of Expert Discovery and Daubert Motion Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/09/2024) (4)
Oct 8, 2024 397 STIPULATION of Dismissal without prejudice as to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. (C.A. No. 22-296) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/08/2024) (3)
Oct 8, 2024 398 STIPULATION of Dismissal without prejudice as to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (C.A. No. 22-298) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/08/2024) (3)
Oct 2, 2024 394 STIPULATION of Dismissal among Novo Nordisk Inc., Novo Nordisk A/S and Mylan Pharmaceuticals Inc. by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/02/2024) (3)
Oct 2, 2024 395 SO ORDERED, re (261 in 1:22-cv-1040, 394 in 1:22-md-3038) Stipulation of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, and Mylan Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 10/2/2024. (mws) (Entered: 10/02/2024) (3)
Oct 2, 2024 396 NOTICE to Take Deposition of Mikhail Kosiborod (Amended) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 10/02/2024) (4)
Sep 25, 2024 392 Joint STIPULATION and [Proposed] Order Regarding the '343 Patent - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/25/2024) (5)
Sep 25, 2024 393 SO ORDERED, re (392 in 1:22-md-03038-CFC-EGT, 344 in 1:22-cv-00294-CFC-EGT) Joint STIPULATION and Order Regarding the '343 Patent. Signed by Judge Colm F. Connolly on 9/25/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT(mws) (Entered: 09/25/2024) (5)
Sep 19, 2024 391 NOTICE requesting Clerk to remove Silvia M. Medina as co-counsel. Reason for request: no longer with the firm. (Murray, Travis) (Entered: 09/19/2024) (7)
Sep 18, 2024 390 Official Transcript of Telephone Conference held on September 12, 2024 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: Bonnie_Archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 10/9/2024. Redacted Transcript Deadline set for 10/21/2024. Release of Transcript Restriction set for 12/17/2024. (nmf) (Entered: 09/18/2024) (11)
Sep 11, 2024 388 STIPULATION and [Proposed] Order to Extend Close of Expert Discovery and Daubert Motion Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/11/2024) (5)
Sep 11, 2024 389 SO ORDERED, re (388 in 1:22-md-03038-CFC-EGT, 338 in 1:22-cv-00294-CFC-EGT, 255 in 1:22-cv-01040-CFC-EGT) Stipulation to Extend Close of Expert Discovery and Daubert Motion Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Scheduling Order Deadlines: Expert Discovery due by 10/9/2024. Signed by Judge Colm F. Connolly on 9/11/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-01040-CFC-EGT, 1:22-md-03038-CFC-EGT (kmd) (Entered: 09/11/2024) (5)
Sep 10, 2024 387 NOTICE of Appearance by Sara M. Metzler on behalf of Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc. (Metzler, Sara) (Entered: 09/10/2024) (2)
Sep 9, 2024 386 Letter to The Honorable Colm F. Connolly from Travis J. Murray regarding the date of the pretrial conference. (Murray, Travis) (Entered: 09/09/2024) (2)
Aug 30, 2024 385 NOTICE to Take Deposition of Christopher A. Vellturo on September 5, 2024 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Stombaugh, Alexis) (Entered: 08/30/2024) (6)
Aug 21, 2024 384 NOTICE to Take Deposition of George Grunberger on August 28, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/21/2024) (7)
Aug 20, 2024 382 SO ORDERED, re (251 in 1:22-cv-01040-CFC-EGT, 381 in 1:22-md-03038-CFC-EGT, 331 in 1:22-cv-00294-CFC-EGT) STIPULATION TO EXTEND TIME for Close of Expert Discovery and Daubert Motion Deadlines to Various Dates, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 8/20/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-01040-CFC-EGT (kmd) (Entered: 08/20/2024) (7)
Aug 20, 2024 383 NOTICE to Take Deposition of John B. Buse, M.D., PH.D. on August 30, 2024 at 9:00 am filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 08/20/2024) (5)
Aug 19, 2024 381 STIPULATION TO EXTEND TIME for Close of Expert Discovery and Daubert Motion Deadlines to Various Dates - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/19/2024) (7)
Aug 16, 2024 373 NOTICE to Take Deposition of Virginia W. Cornish, Ph.D. on August 27, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/16/2024) (7)
Aug 16, 2024 374 NOTICE to Take Deposition of William J. Jusko, Ph.D. on August 30, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/16/2024) (7)
Aug 16, 2024 375 NOTICE to Take Deposition of Arthur Z. Schwartzbard, M.D., F.A.C.C. on August 30, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/16/2024) (7)
Aug 16, 2024 376 NOTICE to Take Deposition of Paul Dalby, Ph.D. on September 10, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/16/2024) (7)
Aug 16, 2024 377 NOTICE to Take Deposition of John P. Bantle, M.D. on September 12, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/16/2024) (7)
Aug 16, 2024 378 NOTICE to Take Deposition of Patrick J. Sinko, Ph.D. on August 21, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/16/2024) (6)
Aug 16, 2024 379 NOTICE to Take Deposition of Michael E. Trautmann, M.D. on September 5, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/16/2024) (6)
Aug 16, 2024 380 NOTICE to Take Deposition of Mikhail Kosiborod, M.D. on September 5, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/16/2024) (6)
Aug 11, 2024 372 NOTICE to Take Deposition of Christopher A. Vellturo, Ph.D. on August 13, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/11/2024) (6)
Aug 8, 2024 371 STIPULATION Regarding Invalidity Grounds for U.S. Patent No. 10,335,462 by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 08/08/2024) (9)
Aug 6, 2024 368 NOTICE to Take Deposition of Thomas W. Muir, Ph.D. on August 9, 2024 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 08/06/2024) (5)
Aug 6, 2024 369 NOTICE to Take Deposition of Randall Zusman, M.D. on August 13, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/06/2024) (7)
Aug 6, 2024 370 NOTICE to Take Deposition of Herbert Lin, M.D., Ph.D. on August 16, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/06/2024) (7)
Aug 5, 2024 366 NOTICE to Take Deposition of Lee M. Kaplan, MD,PhD on August 14, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/05/2024) (6)
Aug 5, 2024 367 NOTICE to Take Deposition of Matthew R. Weir, M.D. on August 8, 2024 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/05/2024) (6)
Aug 1, 2024 363 NOTICE of Order Issued in Parallel Inter Partes Review by Novo Nordisk A/S, Novo Nordisk Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Murray, Travis) (Entered: 08/01/2024) (0)
Aug 1, 2024 364 MOTION for Pro Hac Vice Appearance of Attorney Christopher D. Jones - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 08/01/2024) (4)
Aug 1, 2024 365 Pro Hac Vice Fee - Credit Card Payment received for Christopher D. Jones. ( re 364 MOTION for Pro Hac Vice Appearance of Attorney Christopher D. Jones )( Payment of $ 50, receipt number ADEDC-4466635).(Stamoulis, Stamatios) (Entered: 08/01/2024) (0)
Jul 31, 2024 360 Official Transcript of Discovery Teleconference held on 07/19/2024 before Judge Eleanor G. Tennyson. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/21/2024. Redacted Transcript Deadline set for 9/3/2024. Release of Transcript Restriction set for 10/29/2024. (dh) (Entered: 07/31/2024) (22)
Jul 31, 2024 361 MOTION for Pro Hac Vice Appearance of Attorney Courtney M. Prochnow, Ph.D. - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 07/31/2024) (4)
Jul 31, 2024 362 Pro Hac Vice Fee - Credit Card Payment received for Courtney M. Prochnow, Ph.D.. ( re 361 MOTION for Pro Hac Vice Appearance of Attorney Courtney M. Prochnow, Ph.D. )( Payment of $ 50, receipt number ADEDC-4465658).(Stamoulis, Stamatios) (Entered: 07/31/2024) (0)
Jul 30, 2024 358 NOTICE to Take Deposition of Dr. Allen Spiegel on July 31, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 07/30/2024) (7)
Jul 30, 2024 359 NOTICE to Take Deposition of DeForest McDuff, Ph.D. on August 1, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 07/30/2024) (7)
Jul 18, 2024 357 MOTION for Pro Hac Vice Appearance of Attorney Aaron M. Johnson - filed by EMS S/A, Rio Biopharmaceuticals, Inc.. (Hitch, Cortlan) (Entered: 07/18/2024) (2)
Jul 17, 2024 353 Letter to The Honorable Eleanor G. Tennyson from Travis J. Murray regarding Discovery Dispute - re (224 in 1:22-cv-01040-CFC-EGT, 352 in 1:22-md-03038-CFC-EGT) Letter,. (Attachments: # 1 Ex. C, # 2 Ex. D)(Murray, Travis) (Entered: 07/17/2024) (0)
Jul 17, 2024 354 NOTICE OF SERVICE of (1) Defendants' Joint Reply expert Report of Dr. Paul Dalby; (2) Defendants' Joint Reply Expert Report of William J. Jusko, Ph.D. regarding Invalidity of U.S. Patent No. 10,335,492 and; (3) Defendants' Joint Reply Expert Report of Dr. John Bantle regarding Invalidity of U.S. No. 10,335,462 filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Hitch, Cortlan) (Entered: 07/17/2024) (3)
Jul 17, 2024 355 NOTICE OF SERVICE of (1) Reply Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Objective Indicia; (2) Reply Expert Report of Plaintiffs' Expert Lee M. Kaplan, M.D., Ph.D.; (3) Reply Expert Report of Plaintiffs' Expert Mikhail N. Kosiborod, M.D.; (4) Reply Expert Report of Plaintiffs' Expert Thomas W. Muir, Ph.D.; (5) Reply Expert Report of Christopher A. Vellturo, Ph.D.; (6) Reply Expert Report of Plaintiffs' Expert Matthew R. Weir, M.D.; (7) Reply Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Dr. Reddy's Laboratories Ltd. & Dr. Reddy's Laboratories, Inc., Sun Pharmaceutical Industries Ltd. & Sun Pharmaceutical Industries, Inc., and Mylan Pharmaceuticals Inc.; and (8) Reply Expert Report of Plaintiffs' Expert Patrick Sinko, Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Dr. Reddy's Laboratories Ltd. & Dr. Reddy's Laboratories, Inc., Sun Pharmaceutical Industries Ltd. & Sun Pharmaceutical Industries, Inc. and Mylan Pharmaceuticals Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 07/17/2024) (14)
Jul 17, 2024 356 NOTICE OF SERVICE of the Reply Expert Report of Virginia W. Cornish, Ph.D. on Validity of U.S. Patent No. 8,129,343 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc..(Metzler, Sara) (Entered: 07/17/2024) (3)
Jul 16, 2024 351 MOTION for Discovery Dispute Resolution - filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Certificate of Compliance with Local Rule 7.1.1)Motions referred to Eleanor G. Tennyson.(Stamoulis, Stamatios) (Entered: 07/16/2024) (0)
Jul 16, 2024 352 Letter to the Honorable Eleanor G. Tennyson from Stamatios Stamoulis regarding Discovery Dispute on Expert Reports - re (223 in 1:22-cv-01040-CFC, 351 in 1:22-md-03038-CFC) MOTION for Discovery Dispute Resolution. (Attachments: # 1 Exhibit A-B)(Stamoulis, Stamatios) (Entered: 07/16/2024) (0)
Jul 12, 2024 348 ORAL ORDER - In light of the recent referral of discovery disputes to the undersigned, IT IS HEREBY ORDERED that the briefing for the July 19, 2024 discovery conference shall proceed consistent with the Scheduling Order entered in this case. IT IS FURTHER ORDERED that the July 19, 2024 hearing is converted to a teleconference. Counsel shall provide a dial-in number for the teleconference by emailing egt_civil@ded.uscourts.gov. ORDERED by Judge Eleanor G. Tennyson on 7/12/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC. (Entered: 07/12/2024) (0)
Jul 12, 2024 349 Joint STIPULATION TO EXTEND TIME Reply Expert Reports to July 16, 2024 and Close of Expert Discovery August 19, 2024 - filed by Mylan Pharmaceuticals Inc. (Stamoulis, Stamatios) Modified on 7/16/2024 (nmf). (Entered: 07/12/2024) (6)
Jul 12, 2024 350 SO ORDERED, re (349 in 1:22-md-03038-CFC, 221 in 1:22-cv-01040-CFC, 305 in 1:22-cv-00294-CFC) Joint STIPULATION TO EXTEND TIME Reply Expert Reports to July 16, 2024 and Close of Expert Discovery August 19, 2024. ORDER Resetting Scheduling Order Deadlines: Rebuttal Expert Reports due by 7/16/2024. Expert Discovery due by 8/19/2024. Signed by Judge Colm F. Connolly on 7/12/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC (kmd) Modified on 7/16/2024 (nmf). (Entered: 07/12/2024) (6)
Jun 17, 2024 347 NOTICE OF SERVICE of (1) Rebuttal Expert Report of Plaintiffs' Expert Thomas W. Muir, Ph.D. and (2) Rebuttal Expert Report of Plaintiffs' Expert Michael E. Trautmann, M.D. Regarding U.S. Patent No. 8,129,343 - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 06/17/2024) (10)
Jun 3, 2024 344 NOTICE OF SERVICE of (i) Responsive Expert Report of Randall Zusman, M.D. [CONFIDENTIAL]; and, (ii) the accompanying production bates labeled SEMA(DMS)_0000001-SEMA(DMS)_0000055 filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 06/03/2024) (3)
Jun 3, 2024 345 NOTICE OF SERVICE of (1) Rebuttal Expert Report of Michael E. Trautmann, M.D. Regarding Validity of U.S. Patent No. 10,335,462 and (2) Rebuttal Expert Report of Patrick Sinko, Ph.D. Regarding Validity of U.S. Patent No. 10,335,462 - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 06/03/2024) (10)
Jun 3, 2024 346 NOTICE OF SERVICE of (1) Rebuttal Expert Report of Dr. Herbert Lin Regarding U.S. Patent Nos. 8,129,343 and 10,335,462, (2) Rebuttal Expert Report of Virginia W. Cornish, Ph.D., on Objective Indicia of U.S. Patent 8,129,343, (3) Responsive Expert Report of Arthur Z. Schwartzbard, M.D., F.A.C.C., (4) Rebuttal Expert Report of Dr. Allen Spiegel Regarding Invalidity of U.S. Patent No. 10,335,462, (5) Rebuttal Expert Report of Dr. George Grunberger Regarding Invalidity of U.S. Patent No. 10,335,462, and (6) Expert Report of DeForest McDuff, Ph.D. filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 06/03/2024) (3)
May 31, 2024 342 Joint STIPULATION and [Proposed] Order Amending Certain Expert Discovery Deadlines by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/31/2024) (5)
May 31, 2024 343 SO ORDERED, re (298 in 1:22-cv-00294-CFC, 214 in 1:22-cv-01040-CFC, 342 in 1:22-md-03038-CFC) Stipulation Amending Certain Expert Discovery Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/31/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 05/31/2024) (5)
May 27, 2024 340 MOTION for Pro Hac Vice Appearance of Attorney Aaron E. Schindler - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 05/27/2024) (4)
May 27, 2024 341 Pro Hac Vice Fee - Credit Card Payment received for Aaron E. Schindler. ( re 340 MOTION for Pro Hac Vice Appearance of Attorney Aaron E. Schindler )( Payment of $ 50, receipt number ADEDC-4415731).(Stamoulis, Stamatios) (Entered: 05/27/2024) (0)
May 17, 2024 339 NOTICE OF SERVICE of Opening Expert Report of Virginia W. Cornish, Ph.D. Regarding Invalidity of U.S. Patent 8,129,343 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 05/17/2024) (3)
May 14, 2024 335 STIPULATION and [Proposed] Order Amending Certain Case Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/14/2024) (6)
May 14, 2024 336 MOTION for Pro Hac Vice Appearance of Attorney Kyu Yun Kim of FENWICK & WEST LLP - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/14/2024) (7)
May 14, 2024 337 Pro Hac Vice Fee - Credit Card Payment received for Kyu Yun Kim of FENWICK & WEST LLP. ( re 336 MOTION for Pro Hac Vice Appearance of Attorney Kyu Yun Kim of FENWICK & WEST LLP )( Payment of $ 50, receipt number ADEDC-4406746).(Murray, Travis) (Entered: 05/14/2024) (0)
May 14, 2024 338 SO ORDERED, re (335 in 1:22-md-03038-CFC, 207 in 1:22-cv-01040-CFC, 293 in 1:22-cv-00294-CFC) STIPULATION and Order Amending Certain Case Deadlines. ORDER Resetting Scheduling Order Deadlines: ( A Final Pretrial Conference is set for 10/29/2024 at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly., Expert Discovery due by 8/16/2024., Proposed Pretrial Order due by 10/8/2024.) SEE ORDER FOR FURTHER DETAILS. Signed by Judge Colm F. Connolly on 5/14/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) (Entered: 05/14/2024) (6)
May 3, 2024 334 STIPULATION Concerning Invalidity Grounds by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 05/03/2024) (3)
May 1, 2024 333 STIPULATION of Invalidity Contentions by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc.. (Metzler, Sara) (Entered: 05/01/2024) (3)
Apr 29, 2024 332 SO ORDERED, re (205 in 1:22-cv-01040-CFC) STIPULATION TO EXTEND TIME to serve rebuttal expert reports to May 24, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc., (289 in 1:22-cv-00294-CFC, 331 in 1:22-md-03038-CFC) STIPULATION TO EXTEND TIME to serve rebuttal expert reports to May 24, 2024 filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 4/29/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) (Entered: 04/29/2024) (6)
Apr 26, 2024 331 STIPULATION TO EXTEND TIME to serve rebuttal expert reports to May 24, 2024 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 04/26/2024) (6)
Mar 20, 2024 328 NOTICE OF SERVICE of the Opening Expert Report of Zhaohui Sunny Zhou, Ph.D. Regarding Invalidity of U.S. Patent 8,129,343 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 03/20/2024) (3)
Mar 20, 2024 329 NOTICE OF SERVICE of (1) Opening Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Objective Indicia, (2) Opening Expert Report of Plaintiffs' Expert Thomas W. Muir, Ph.D., (3) Opening Expert Report of Plaintiffs' Expert Mikhail N. Kosiborod, M.D., (4) Opening Expert Report of Plaintiffs' Expert Lee M. Kaplan, M.D., Ph.D., (5) Opening Expert Report of Plaintiffs' Expert Matthew R. Weir, M.D., (6) Opening Expert Report of Christopher A. Vellturo, Ph.D., (7) Opening Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Mylan Pharmaceuticals Inc., (8) Opening Expert Report of Plaintiffs' Expert Patrick J. Sinko, Ph.D. Regarding Infringement by Defendants Mylan Pharmaceuticals Inc., (9) Opening Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Sun Pharmaceutical Industries Ltd. and Sun Pharmaceuticals Industries Inc., (10) Opening Expert Report of Plaintiffs' Expert William R. Roush, Ph.D. Regarding Infringement by Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceuticals Industries, Inc., (11) Opening Expert Report of Plaintiffs' Expert Patrick J. Sinko, Ph.D. Regarding Infringement by Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceuticals Industries, Inc., (12) Opening Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Rio Biopharmaceuticals Inc. and EMS S/A, (13) Opening Expert Report of Plaintiffs' Expert William R. Roush, Ph.D. Regarding Infringement by Defendants Rio Pharmaceuticals Incorporated and EMS S/A, (14) Opening Expert Report of Plaintiffs' Expert Patrick J. Sinko, Ph.D. Regarding Infringement by Defendants Rio Biopharmaceuticals Inc. and EMS S/A, (15) Opening Expert Report of Plaintiffs' Expert John B. Buse, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 10,335,462 by Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc., (16) Opening Expert Report of Plaintiffs' Expert Patrick J. Sinko, Ph.D. Regarding Infringement by Defendants Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/20/2024) (15)
Mar 20, 2024 330 NOTICE OF SERVICE of (1) Opening Expert Report of William J. Jusko, Ph.D. Regarding Invalidity of U.S. Patent No. 10,335,462, (2) Opening Expert Report of Dr. John Bantle Regarding Invalidity of U.S. Patent No. 10,335,462, and (3) Opening Expert Report of Dr. Paul Dalby Regarding Invalidity of U.S. Patent No. 10,335,462 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 03/20/2024) (2)
Mar 18, 2024 326 REDACTED VERSION of (280 in 1:22-cv-00294-CFC, 322 in 1:22-md-03038-CFC) Stipulation, by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 03/18/2024) (5)
Mar 18, 2024 327 REDACTED VERSION of (323 in 1:22-md-03038-CFC, 281 in 1:22-cv-00294-CFC) SO ORDERED, by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 03/18/2024) (5)
Mar 15, 2024 325 SO ORDERED, re (200 in 1:22-cv-01040-CFC, 324 in 1:22-md-03038-CFC, 282 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME Certain Deadlines Related to Experts to See Stipulation, filed by Mylan Pharmaceuticals Inc. Reset Scheduling Order Deadlines: Opening Expert Reports due by 3/19/2024. Rebuttal Expert Reports due by 4/26/2024. Expert Discovery due by 7/3/2024. Signed by Judge Colm F. Connolly on 3/15/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-01040-CFC, 1:22-md-03038-CFC (kmd) (Entered: 03/15/2024) (5)
Mar 14, 2024 324 STIPULATION TO EXTEND TIME Certain Deadlines Related to Experts to See Stipulation - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 03/14/2024) (5)
Mar 13, 2024 323 [SEALED] SO ORDERED, re (280 in 1:22-cv-00294-CFC, 322 in 1:22-md-03038-CFC) Stipulation Regarding Infringement of the '343 Patent by DRL Defendants and Dismissal as to DRL Defendants Regarding the '383 and '953 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 3/13/2024. This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC (kmd) (Entered: 03/13/2024) (0)
Mar 12, 2024 322 [SEALED] STIPULATION and [Proposed] Order Regarding Infringement of the '343 Patent by DRL Defendants and Dismissal as to DRL Defendants Regarding the '383 and '953 Patents by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 03/12/2024) (0)
Mar 11, 2024 321 SO ORDERED, re (198 in 1:22-cv-01040-CFC, 320 in 1:22-md-03038-CFC) Stipulation Regarding the '343, '122, '383, and '953 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 3/11/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC (kmd) (Entered: 03/11/2024) (7)
Mar 8, 2024 320 STIPULATION and [Proposed] Order Regarding the '343, '122, '383, and '953 Patents - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 03/08/2024) (7)
Mar 6, 2024 319 NOTICE OF SERVICE of Plaintiffs' Responses to Defendant's Third Supplemental Invalidity Contentions Regarding U.S. Patent Nos. 8,920,383 and 9,775,953 - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 03/06/2024) (7)
Mar 5, 2024 317 NOTICE OF SERVICE of DRL's Supplemental Noninfringement Contentions for U.S. Patent Nos. 8,920,383 and 9,775,953 [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 03/05/2024) (2)
Mar 5, 2024 318 NOTICE OF SERVICE of Defendants Second Supplemental Noninfringement Contentions filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 03/05/2024) (2)
Feb 29, 2024 315 STIPULATION TO EXTEND TIME to Supplement Noninfringement Contentions and Responses to Invalidity Contentions for the '953 and '383 patents to March 5, 2024 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 02/29/2024) (3)
Feb 29, 2024 316 SO ORDERED, re (315 in 1:22-md-03038-CFC, 276 in 1:22-cv-00294-CFC, 194 in 1:22-cv-01040-CFC) STIPULATION TO EXTEND TIME to Supplement Noninfringement Contentions and Responses to Invalidity Contentions for the '953 and '383 patents to March 5, 2024, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 2/29/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-01040-CFC, 1:22-md-03038-CFC (kmd) (Entered: 02/29/2024) (3)
Feb 26, 2024 314 STIPULATION of Invalidity Contentions by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc.. (Metzler, Sara) (Entered: 02/26/2024) (3)
Feb 21, 2024 313 SO ORDERED, re (192 in 1:22-cv-01040-CFC, 312 in 1:22-md-03038-CFC, 273 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME for the Deadline to Supplement Noninfringement Contentions and Responses to Invalidity Contentions for the 953 and 383 patents to February 29, 2024, filed by Mylan Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 2/21/2024. Associated Cases: 1:22-cv-01040-CFC, 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 02/21/2024) (3)
Feb 20, 2024 312 STIPULATION TO EXTEND TIME for the Deadline to Supplement Noninfringement Contentions and Responses to Invalidity Contentions for the 953 and 383 patents to February 29, 2024 - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 02/20/2024) (3)
Feb 13, 2024 311 NOTICE OF SERVICE of Sun's Final Non-Infringement Contentions filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc..(Metzler, Sara) (Entered: 02/13/2024) (2)
Feb 12, 2024 310 NOTICE OF SERVICE of Novo Nordisk's Responses to Defendants' Second Supplemental Invalidity Contentions Regarding U.S. Patent Nos. 8,129,343; 8,536,122; and 10,335,462 - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/12/2024) (11)
Feb 9, 2024 308 NOTICE OF SERVICE of DRL's First Amended Noninfringement Contentions regarding the 343 Patent and Second Amended Noninfringement Contentions regarding the 462 Patent [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 02/09/2024) (2)
Feb 9, 2024 309 STIPULATION TO EXTEND TIME of Certain Deadlines Related to Experts to See Stipulation - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 02/09/2024) (3)
Feb 8, 2024 307 REDACTED VERSION of (266 in 1:22-cv-00294-CFC, 304 in 1:22-md-03038-CFC) Stipulation - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 02/08/2024) (4)
Feb 6, 2024 305 SO ORDERED, re (300 in 1:22-md-03038-CFC, 186 in 1:22-cv-01040-CFC) STIPULATION TO EXTEND TIME Fact Discovery Cutoff to February 14, 2024, filed by Mylan Pharmaceuticals Inc. Reset Scheduling Order Deadlines: Fact Discovery completed by 2/14/2024. Signed by Judge Colm F. Connolly on 2/6/2024. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC (kmd) (Entered: 02/06/2024) (3)
Feb 6, 2024 306 [SEALED] SO ORDERED, re (266 in 1:22-cv-00294-CFC, 304 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Sun Regarding the '383 and '953 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc.. Signed by Judge Colm F. Connolly on 2/6/2024. This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC (kmd) (Entered: 02/06/2024) (0)
Feb 5, 2024 304 [SEALED] STIPULATION and [Proposed] Order of Dismissal as to Sun Regarding the '383 and '953 Patents - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 02/05/2024) (0)
Feb 1, 2024 301 NOTICE OF SERVICE of Defendants' Third Supplemental Invalidity Contentions (with Exhibits D and E) [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 02/01/2024) (2)
Feb 1, 2024 302 NOTICE OF SERVICE of Plaintiffs' Amended Infringement Contentions as to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Regarding the '383 and '953 Patents - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/01/2024) (5)
Feb 1, 2024 303 NOTICE OF SERVICE of Plaintiffs' Amended Infringement Contentions as to Mylan Pharmaceuticals Inc. Regarding the '383 and '953 Patents - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 02/01/2024) (4)
Jan 31, 2024 299 SO ORDERED, re (298 in 1:22-md-03038-CFC, 262 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME for Novo Nordisk to serve on Sun supplemental infringement contentions and for Sun to serve on Novo Nordisk supplemental invalidity contentions as to the '383 patent and the '953 patent to February 8, 2024, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 1/31/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 01/31/2024) (3)
Jan 31, 2024 300 STIPULATION TO EXTEND TIME Fact Discovery Cutoff to February 14, 2024 - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 01/31/2024) (3)
Jan 30, 2024 298 STIPULATION TO EXTEND TIME for Novo Nordisk to serve on Sun supplemental infringement contentions and for Sun to serve on Novo Nordisk supplemental invalidity contentions as to the '383 patent and the '953 patent to February 8, 2024 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/30/2024) (3)
Jan 19, 2024 296 NOTICE OF SERVICE of Plaintiffs' Final Election of Asserted Claims for U.S. Patent No. 8,950,383 and U.S. Patent No. 9,775,953 to Defendant Mylan Pharmaceuticals Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/19/2024) (5)
Jan 19, 2024 297 NOTICE OF SERVICE of (1) Plaintiffs' Final Election of Asserted Claims for U.S. Patent No. 8,950,383 and U.S. Patent No. 9,775,953 to Defendants Dr. Reddy's Laboratories, Inc., and Dr. Reddy's Laboratories, Ltd. and (2) Plaintiffs' Final Election of Asserted Claims for U.S. Patent No. 8,950,383 and U.S. Patent No. 9,775,953 to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/19/2024) (8)
Jan 16, 2024 293 NOTICE OF SERVICE of Plaintiffs' Amended Infringement Contentions as to Mylan Pharmaceuticals Inc. Regarding the '343, '122, and '462 Patents - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/16/2024) (5)
Jan 16, 2024 294 NOTICE OF SERVICE of (1) Plaintiffs' Amended Infringement Contentions as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '343 and '462 Patents, (2) Plaintiffs' Amended Infringement Contentions as to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc. Regarding the '343 and '462 Patents, and (3) Plaintiffs' Amended Infringement Contentions as to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Regarding the '343 and '462 Patents - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/16/2024) (9)
Jan 16, 2024 295 NOTICE OF SERVICE of Defendants' Final Disclosure of Prior Art regarding the 383 and 953 Patents [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 01/16/2024) (2)
Jan 12, 2024 292 SO ORDERED, re (291 in 1:22-md-03038-CFC, 257 in 1:22-cv-00294-CFC) Stipulation Regarding Authenticity and Business Record Status of Documents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 1/12/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC (kmd) (Entered: 01/12/2024) (6)
Jan 11, 2024 291 Joint STIPULATION and [Proposed] Order Regarding Authenticity and Business Record Status of Documents by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/11/2024) (6)
Jan 10, 2024 285 STIPULATION and [Proposed] Order Regarding Authenticity and Business Record Status of Documents (as to Defendant Mylan Pharmaceuticals Inc.) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/10/2024) (9)
Jan 10, 2024 286 SO ORDERED, re (252 in 1:22-cv-00294-CFC, 285 in 1:22-md-03038-CFC, 179 in 1:22-cv-01040-CFC) Stipulation Regarding Authenticity and Business Record Status of Documents (as to Defendant Mylan Pharmaceuticals Inc.), filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 1/10/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-01040-CFC, 1:22-md-03038-CFC (kmd) (Entered: 01/10/2024) (9)
Jan 10, 2024 287 STIPULATION and [Proposed] Order of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, and Alvogen Inc. - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/10/2024) (3)
Jan 10, 2024 288 SO ORDERED, re (287 in 1:22-md-03038-CFC, 254 in 1:22-cv-00294-CFC) Stipulation of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, and Alvogen Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 1/10/2024. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00299-CFC, 1:22-md-03038-CFC (kmd) (Entered: 01/10/2024) (3)
Jan 10, 2024 289 NOTICE OF SERVICE of Defendants' Supplemental Preliminary Disclosure of Prior Art Regarding the '383 and '953 Patents filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 01/10/2024) (2)
Jan 10, 2024 290 NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to MPI Regarding U.S. Patent Nos. 8,920,383 and 9,775,953 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 01/10/2024) (5)
Dec 27, 2023 284 SO ORDERED, re (250 in 1:22-cv-00294-CFC, 283 in 1:22-md-03038-CFC) Stipulation Regarding Authenticity and Business Record Status of Documents (as to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited), filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/27/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC (kmd) (Entered: 12/27/2023) (7)
Dec 21, 2023 283 STIPULATION and [Proposed] Order Regarding Authenticity and Business Record Status of Documents (as to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/21/2023) (7)
Dec 19, 2023 282 SO ORDERED, re (248 in 1:22-cv-00294-CFC, 281 in 1:22-md-03038-CFC) Stipulation Regarding Authenticity and Business Record Status of Documents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/19/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC (kmd) (Entered: 12/19/2023) (7)
Dec 18, 2023 281 Joint STIPULATION and [Proposed] Order Regarding Authenticity and Business Record Status of Documents by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) (Entered: 12/18/2023) (7)
Dec 14, 2023 280 SO ORDERED, re (278 in 1:22-md-03038-CFC, 245 in 1:22-cv-00294-CFC) Stipulation Regarding Authenticity and Business Record Status of Documents (as to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.), filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/14/2023. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 12/14/2023) (7)
Dec 13, 2023 277 STIPULATION and [Proposed] Order Further Amending Scheduling Order by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 12/13/2023) (5)
Dec 13, 2023 278 STIPULATION and [Proposed] Order Regarding Authenticity and Business Record Status of Documents (as to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/13/2023) (7)
Dec 13, 2023 279 SO ORDERED, re (277 in 1:22-md-03038-CFC, 244 in 1:22-cv-00294-CFC, 175 in 1:22-cv-01040-CFC) Stipulation Further Amending Scheduling Order, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. Signed by Judge Colm F. Connolly on 12/13/2023. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-01040-CFC, 1:22-md-03038-CFC (kmd) (Entered: 12/13/2023) (5)
Dec 12, 2023 276 REDACTED VERSION of (271 in 1:22-md-03038-CFC, 239 in 1:22-cv-00294-CFC) Stipulation of Dismissal by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc.. (Farnan, Kelly) (Entered: 12/12/2023) (3)
Dec 11, 2023 275 SUPPLEMENTAL CLAIM CONSTRUCTION ORDER re (274 in 1:22-md-03038-CFC, 173 in 1:22-cv-01040-CFC, 241 in 1:22-cv-00294-CFC) Letter, ORDER, terminating Deadlines/Hearings: The Supplemental Markman briefing deadlines and the January 11, 2024 Supplemental Markman hearing are vacated. Signed by Judge Colm F. Connolly on 12/11/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) (Entered: 12/11/2023) (4)
Dec 8, 2023 274 Letter to The Honorable Colm F. COnnolly from Travis Murray regarding remaining claim construction terms in dispute. (Attachments: # 1 [Proposed] Supplemental Claim Construction Order)(Murray, Travis) (Entered: 12/08/2023) (0)
Dec 7, 2023 273 NOTICE to Take Deposition of Thomas Kruse Hansen on December 8, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 12/07/2023) (5)
Dec 5, 2023 271 [SEALED] STIPULATION of Dismissal and [Proposed] Order as to Sun Regarding the '239 and '154 Patents by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc.. (Farnan, Kelly) (Entered: 12/05/2023) (0)
Dec 5, 2023 272 [SEALED] SO ORDERED, re (271 in 1:22-md-03038-CFC, 239 in 1:22-cv-00294-CFC) Stipulation of Dismissal as to Sun Regarding the '239 and '154 Patents, filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc. Signed by Judge Colm F. Connolly on 12/5/2023. This order has been emailed to local counsel. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC (kmd) (Entered: 12/05/2023) (0)
Dec 4, 2023 269 STIPULATION and [Proposed] Order Regarding Depositions of DRL Foreign Witness - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/04/2023) (4)
Dec 4, 2023 270 SO ORDERED, re (237 in 1:22-cv-00294-CFC, 269 in 1:22-md-03038-CFC) Stipulation Regarding Depositions of DRL Foreign Witness, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/4/2023. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 12/04/2023) (4)
Dec 1, 2023 268 SO ORDERED, re (267 in 1:22-md-03038-CFC, 170 in 1:22-cv-01040-CFC, 235 in 1:22-cv-00294-CFC) Stipulation Amending Scheduling Order, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. Resetting Scheduling Order Deadlines: Fact Discovery completed by 12/15/2023. Opening Expert Reports due by 3/1/2024. Rebuttal Expert Reports due by 4/5/2024. Expert Discovery due by 6/7/2024. Signed by Judge Colm F. Connolly on 12/1/2023. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-01040-CFC, 1:22-md-03038-CFC(kmd) (Entered: 12/01/2023) (7)
Nov 30, 2023 267 STIPULATION Amending Scheduling Order with [Proposed] Order by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 11/30/2023) (7)
Nov 20, 2023 262 NOTICE to Take Deposition of Pradeep Patil on November 30, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/20/2023) (4)
Nov 20, 2023 263 STIPULATION and [Proposed] Order Regarding Depositions of Certain Sun Foreign Witnesses by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/20/2023) (4)
Nov 20, 2023 264 SO ORDERED, re (167 in 1:22-cv-01040-CFC, 261 in 1:22-md-03038-CFC, 230 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME for Supplemental Claim Construction Briefs and Expert Declarations to December 11, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Deadlines for Claim Construction Briefing and Markman Hearing: Joint Claim Construction Brief due by 12/11/2023. Signed by Judge Colm F. Connolly on 11/20/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 11/20/2023) (4)
Nov 20, 2023 265 NOTICE to Take Deposition of Stephanie DeChiaro on November 21, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 11/20/2023) (5)
Nov 20, 2023 266 SO ORDERED, re (263 in 1:22-md-03038-CFC, 232 in 1:22-cv-00294-CFC) Stipulation Regarding Depositions of Certain Sun Foreign Witnesses, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 11/20/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) (Entered: 11/20/2023) (4)
Nov 17, 2023 261 STIPULATION TO EXTEND TIME for Supplemental Claim Construction Briefs and Expert Declarations to December 11, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/17/2023) (4)
Nov 14, 2023 260 MOTION for Pro Hac Vice Appearance of Attorney Maria A. Stubbings - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 11/14/2023) (4)
Nov 13, 2023 259 NOTICE to Take Deposition of Vanessa Costain on November 15, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 11/13/2023) (5)
Nov 10, 2023 258 NOTICE OF SERVICE of (1) Defendants Rio Biopharmaceuticals Inc. and EMS S/A's Responses and Objections to Plaintiffs' Fourth Set of Collective Interrogatories (Nos. 15-16) and; (2) Defendants Rio Biopharmaceuticals and EMS S/A's Responses and Objections to Plaintiffs' First Set of Collective Requests for Admission (Nos. 1-24) filed by EMS S/A, Mylan Pharmaceuticals Inc., Novo Nordisk A/S, Novo Nordisk Inc., Ozempic (Semaglutide) Patent Litigation, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 11/10/2023) (3)
Nov 6, 2023 255 SO ORDERED, re (222 in 1:22-cv-00294-CFC, 251 in 1:22-md-03038-CFC) Stipulation Regarding Infringement of U.S. Patent Nos. 8,129,343 and 10,335,462, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 11/6/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) (Entered: 11/06/2023) (6)
Nov 6, 2023 256 NOTICE OF SERVICE of Defendants' Supplemental Invalidity Contentions filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 11/06/2023) (2)
Nov 6, 2023 257 NOTICE OF SERVICE of (1) Sun's Responses and Objections to Plaintiffs' First Set of Requests for Admission to Sun Defendants (Nos. 1-61); (2) Sun's Responses and Objections to Plaintiffs' First Set of Collective Requests for Admission (Nos. 1-24); and (3) Sun's Responses and Objections to Plaintiffs' Fourth Set of Collective Interrogatories (Nos. 15-16) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 11/06/2023) (3)
Nov 3, 2023 249 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Third Set of Requests for Production (Nos. 29-32) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/03/2023) (11)
Nov 3, 2023 250 NOTICE OF SERVICE of (1) Alvogen, Inc.s Responses and Objections to Plaintiffs Fourth Set of Collective Interrogatories (Nos. 15 16), (2) Defendant Alvogen, Inc.s Objections and Responses to Plaintiffs First Set of Requests for Admission to Alvogen, Inc. (Nos. 1 56) and (3) Defendant Alvogen, Inc.s Objections and Responses to Plaintiffs First Set of Collective Requests for Admission to Alvogen, Inc. (Nos. 1 24) filed by Alvogen, Inc..(Keller, Karen) (Entered: 11/03/2023) (3)
Nov 3, 2023 251 STIPULATION and [Proposed] Order Regarding Infringement of U.S. Patent Nos. 8,129,343 and 10,335,462 by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/03/2023) (6)
Nov 3, 2023 252 NOTICE OF SERVICE of Defendant Rio Biopharmaceuticals Inc. and EMS S/A's Responses and Objections to Plaintiffs' First Set of Requests for Admission to Rio (Nos. 1-48) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 11/03/2023) (3)
Nov 3, 2023 253 NOTICE OF SERVICE of (i) Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Objections and Responses to Plaintiff's First Set of Requests for Admission (Nos. 169) [CONFIDENTIAL]; (ii) DRL's Responses and Objection to Plaintiffs' Fourth Set of Collective Interrogatories to Plaintiffs (Nos. 1516); and; (iii) Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Objections and Responses to Plaintiffs' First Set of Collective Requests for Admission (Nos. 1-24) [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 11/03/2023) (3)
Nov 3, 2023 254 NOTICE OF SERVICE of 1) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Fourth Set of Collective Interrogatories to Defendants (Nos. 15-16); and 2) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Objections and Responses to Plaintiffs' First Set of Requests for Admission (No. 10) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Stombaugh, Alexis) (Entered: 11/03/2023) (3)
Nov 2, 2023 247 NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendants' Second Set of Requests for Production (Nos. 24-28); (2) Plaintiffs' Responses and Objections to Defendants' Second Set of Interrogatories (Nos. 5-7); and (3) Plaintiffs' Responses and Objections to Defendants' First Set of Joint Requests for Admission to Plaintiffs (Nos. 1-25) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/02/2023) (11)
Nov 2, 2023 248 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants Rio Biopharmaceuticals Inc. and Ems S/A's First Set of Requests for Admission to Plaintiffs (Nos. 1-14) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/02/2023) (3)
Nov 1, 2023 246 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Alvogen, Inc.'s First Set of Requests for Admission (Nos. 1-15) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/01/2023) (3)
Oct 31, 2023 244 STIPULATION and [Proposed] Order Regarding Trial of the MPI Ozempic Litigation - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/31/2023) (4)
Oct 31, 2023 245 SO ORDERED, re (161 in 1:22-cv-01040-CFC, 244 in 1:22-md-03038-CFC) Stipulation Regarding Trial of the MPI Ozempic Litigation, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 10/31/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 10/31/2023) (4)
Oct 25, 2023 243 NOTICE to Take Deposition of Jesper Lau on October 26, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 10/25/2023) (5)
Oct 20, 2023 241 NOTICE OF SERVICE of Alvogen, Inc.s Amended Rule 26(a)(1) Initial Disclosures filed by Alvogen, Inc..(Keller, Karen) (Entered: 10/20/2023) (3)
Oct 20, 2023 242 Letter to The Honorable Colm F. Connolly from Travis J. Murray regarding expert testimony - re (157 in 1:22-md-03038-CFC, 157 in 1:22-md-03038-CFC) Order,, Set Deadlines/Hearings,. (Murray, Travis) (Entered: 10/20/2023) (2)
Oct 19, 2023 240 SO ORDERED, re (239 in 1:22-md-03038-CFC, 157 in 1:22-cv-01040-CFC, 213 in 1:22-cv-00294-CFC) Stipulation Extending Deadline for Certain Fact Discovery Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 10/19/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC (kmd) (Entered: 10/19/2023) (5)
Oct 18, 2023 239 Joint STIPULATION and [Proposed] Order Extending Deadline for Certain Fact Discovery Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/18/2023) (5)
Oct 17, 2023 237 NOTICE to Take Deposition of Yaswanth Polimetla on October 27, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) (Entered: 10/17/2023) (4)
Oct 17, 2023 238 NOTICE to Take Deposition of Nitin Bhattad on October 31, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) (Entered: 10/17/2023) (4)
Oct 12, 2023 236 MOTION for Pro Hac Vice Appearance of Attorney Ashley Graham and Hannah M. Shankman of Winston & Strawn LLP - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Gattuso, Dominick) (Entered: 10/12/2023) (5)
Oct 6, 2023 235 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Second Notice of Deposition of Novo Nordisk Inc. and Novo Nordisk A/S Pursuant to Fed. R. Civ. P. 30(b)(6) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 10/06/2023) (11)
Sep 29, 2023 234 MOTION for Pro Hac Vice Appearance of Attorney David L. Anstaett - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 09/29/2023) (4)
Sep 28, 2023 232 Joint STIPULATION and [Proposed] Order of Dismissal as to Mylan Pharmaceuticals Inc. Regarding the '833, '969, '002, '239, '154, '180, '611, '757, '155, '616, '652, '063, '679, '443, and '363 Patents by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/28/2023) (5)
Sep 28, 2023 233 SO ORDERED, re (152 in 1:22-cv-01040-CFC, 232 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Mylan Pharmaceuticals Inc. Regarding the '833, '969, '002, '239, '154, '180, '611, '757, '155, '616, '652, '063, '679, '443, and '363 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 9/28/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC (kmd) (Entered: 09/28/2023) (5)
Sep 25, 2023 231 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Notice of Deposition of Novo Nordisk Inc. and Novo Nordisk A/S Pursuant to Fed. R. Civ. P. 30(b)(6) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/25/2023) (11)
Sep 21, 2023 230 NOTICE OF SERVICE of Defendants' Third Set of Requests for Production to Plaintiffs (Nos. 29-32) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) (Entered: 09/21/2023) (2)
Sep 20, 2023 226 NOTICE OF SERVICE of (i) DRL's Amended Objections and Responses to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) and; (ii) DRLs First Amended Initial Disclosures Pursuant to Rule 26(a)(1) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 09/20/2023) (2)
Sep 20, 2023 227 MOTION for Pro Hac Vice Appearance of Attorney Silvia M. Medina - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/20/2023) (9)
Sep 20, 2023 228 NOTICE OF SERVICE of Plaintiffs' Fourth Set of Requests for the Production of Documents and Things (Nos. 169-181) Directed to Defendant Mylan Pharmaceuticals Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/20/2023) (5)
Sep 20, 2023 229 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Collective Requests for Admission to Defendants (Nos. 1-24), (2) Plaintiffs' Fourth Set of Collective Interrogatories to Defendants (Nos. 15-16), (3) Plaintiffs' First Set of Requests for Admission to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (Nos. 1-69), (4) Plaintiffs' First Set of Requests for Admission to Defendant Alvogen, Inc. (Nos. 1-56), (5) Plaintiffs' First Set of Requests for Admission to Defendant Mylan Pharmaceuticals, Inc. (Nos. 1-82), (6) Plaintiffs' First Set of Requests for Admission to Defendants Rio Biopharmaceuticals Inc. and EMS S/A (Nos. 1-48), (7) Plaintiffs' First Set of Requests for Admission to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited (Nos. 1-58), and (8) Plaintiffs' First Set of Requests for Admission to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. (Nos. 1-61) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/20/2023) (17)
Sep 19, 2023 220 NOTICE OF SERVICE of (i) Defendants' First Set of Joint Requests for Admission to Plaintiffs (Nos. 1-25); and, (ii) Defendants' Second Set of Interrogatories to Plaintiffs (Nos. 5-7) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 09/19/2023) (3)
Sep 19, 2023 221 NOTICE OF SERVICE of DRL's Responses and Objections to Plaintiff's Notice of Deposition under Fed. R. Civ. P. 30(b)(6) [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 09/19/2023) (2)
Sep 19, 2023 222 NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's First Set of Requests for Admission to Plaintiffs (Nos. 1-14) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Hitch, Cortlan) (Entered: 09/19/2023) (3)
Sep 19, 2023 223 NOTICE to Take Deposition of 30(b)(6) Corporate Representative filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/19/2023) (7)
Sep 19, 2023 224 NOTICE OF SERVICE of Defendants' Response to Plaintiffs' Notice of Deposition of Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 09/19/2023) (2)
Sep 19, 2023 225 NOTICE OF SERVICE of (1) Defendants Second Notice of Deposition of Novo Nordisk Inc. and Novo Nordisk A/S Pursuant to Fed. R. Civ. P. 30(b)(6) and (2) Defendants Second Set of Requests for Production to Plaintiffs filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/19/2023) (2)
Sep 18, 2023 219 NOTICE OF SERVICE of Alvogen, Inc.'s First Set of Requests for Admission (Nos. 1-15) filed by Alvogen, Inc..(Hoeschen, Nathan) (Entered: 09/18/2023) (3)
Sep 15, 2023 218 NOTICE OF SERVICE of Defendant Alvogen, Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition under Fed. R. Civ. P. 30(b)(6) filed by Alvogen, Inc..(Keller, Karen) (Entered: 09/15/2023) (3)
Sep 14, 2023 217 NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.s Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/14/2023) (2)
Sep 13, 2023 216 MOTION for Pro Hac Vice Appearance of Attorney Vanessa Park-Thompson, Allie Cohen Dolloff, Ryan A. Haddad, Retley G. Locke Jr., Michael Yoon, Michelle E. Irwin and Adeline Miller - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/13/2023) (14)
Sep 8, 2023 215 MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Attorney Philip Y. Kouyoumdjian and Attorney Jaimin H. Shah - filed by EMS S/A, Rio Biopharmaceuticals, Inc.. (Dorsney, Kenneth) (Entered: 09/08/2023) (4)
Sep 7, 2023 189 NOTICE to Take Deposition of Siyawosh Moghaddam (Alvogen) on October 9, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 190 NOTICE to Take Deposition of Jyoti Sachdeva (Alvogen) on October 10, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 191 NOTICE to Take Deposition of Karuna Dixit on October 11, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 192 NOTICE to Take Deposition of Erika Roers (Alvogen) on October 12, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 193 NOTICE to Take Deposition of Vineet Yadav (Alvogen) on October 13, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 194 NOTICE to Take Deposition of Jaya Lakshmi Ayyagari (DRL) on October 2, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 195 NOTICE to Take Deposition of Smiti Kumar (DRL) on October 3, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 196 NOTICE to Take Deposition of Ashok Tyagi (DRL) on October 4, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 197 NOTICE to Take Deposition of Sushil Kisan Kurade (DRL) on October 5, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 198 NOTICE to Take Deposition of Ananda Sandhya K (DRL) on October 6, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 199 NOTICE to Take Deposition of Daniel Salazar (Rio) on September 15, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 200 NOTICE to Take Deposition of Wilberto Maldonado (Rio) on September 18, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 201 NOTICE to Take Deposition of Ana Paula Rodrigues (Rio) on September 19, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 202 NOTICE to Take Deposition of Srinivas Gurram (Zydus) on September 20, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 203 NOTICE to Take Deposition of Debjani Singh on September 21, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 204 NOTICE to Take Deposition of Tushar Nahata (Zydus) on September 22, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (3)
Sep 7, 2023 205 NOTICE to Take Deposition of Praveen Devakadaksham (Sun) on October 16, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4)
Sep 7, 2023 206 NOTICE to Take Deposition of Nilesh Patel (Sun) on October 17, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4)
Sep 7, 2023 207 NOTICE to Take Deposition of Satyashodhan Patil (Sun) on October 18, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4)
Sep 7, 2023 208 NOTICE to Take Deposition of Krupali Trivedi (Sun) on October 19, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4)
Sep 7, 2023 209 NOTICE to Take Deposition of Viral Jogani (Sun) on October 20, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4)
Sep 7, 2023 210 NOTICE to Take Deposition of Beth Britton (Mylan) on September 25, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4)
Sep 7, 2023 211 NOTICE to Take Deposition of Dave Mitchell (Mylan) on September 26, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4)
Sep 7, 2023 212 NOTICE to Take Deposition of Claire McDiarmid (Mylan) on September 27, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4)
Sep 7, 2023 213 NOTICE to Take Deposition of Dilip Jayagopal (Mylan) on September 28, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4)
Sep 7, 2023 214 NOTICE to Take Deposition of Kuntal Maiti (Mylan) on September 29, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/07/2023) (4)
Sep 6, 2023 188 NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's Objections to Plaintiffs' Notice of 30(b)(6) Deposition filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 09/06/2023) (2)
Sep 5, 2023 186 NOTICE OF SERVICE of Plaintiffs' Final Election of Asserted Claims Served on Mylan Pharmaceuticals Inc. -- filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/05/2023) (5)
Sep 5, 2023 187 NOTICE OF SERVICE of Plaintiffs' Final Election of Asserted Claims (Individual Final Elections Served on Each Defendant Group) -- filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/05/2023) (9)
Aug 28, 2023 185 NOTICE requesting Clerk to remove August Melcher as co-counsel.. (Stombaugh, Alexis) (Entered: 08/28/2023) (3)
Aug 25, 2023 175 NOTICE to Take Deposition of Jesper Lau on October 2, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/25/2023) (5)
Aug 25, 2023 176 NOTICE to Take Deposition of Tom Hede Markussen on September 21, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/25/2023) (4)
Aug 25, 2023 177 NOTICE to Take Deposition of Christine Bjoern Jensen on October 11, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/25/2023) (5)
Aug 25, 2023 178 NOTICE to Take Deposition of Claus Mller on September 20, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/25/2023) (4)
Aug 25, 2023 179 NOTICE to Take Deposition of Thomas Kruse Hansen on October 4, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/25/2023) (5)
Aug 25, 2023 180 NOTICE to Take Deposition of Christian Peter Enggaard on September 22, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/25/2023) (5)
Aug 25, 2023 181 NOTICE to Take Deposition of Dorthe Kot Engelund on October 17, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/25/2023) (3)
Aug 25, 2023 182 NOTICE to Take Deposition of Florencio Doerwald on October 9, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/25/2023) (3)
Aug 25, 2023 183 NOTICE to Take Deposition of Tina Bjeldskov Pedersen on October 16, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/25/2023) (3)
Aug 25, 2023 184 NOTICE to Take Deposition of Paw Bloch on October 6, 2023 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/25/2023) (5)
Aug 24, 2023 172 REDACTED VERSION of (166 in 1:22-cv-00294-CFC, 165 in 1:22-md-03038-CFC) Notice to Take Deposition - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/24/2023) (6)
Aug 24, 2023 173 REDACTED VERSION of (124 in 1:22-cv-01040-CFC, 162 in 1:22-md-03038-CFC) Notice to Take Deposition by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/24/2023) (8)
Aug 24, 2023 174 REDACTED VERSION of (166 in 1:22-md-03038-CFC, 167 in 1:22-cv-00294-CFC) Notice to Take Deposition by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/24/2023) (7)
Aug 23, 2023 169 REDACTED VERSION of (167 in 1:22-md-03038-CFC, 168 in 1:22-cv-00294-CFC) Notice to Take Deposition - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/23/2023) (7)
Aug 23, 2023 170 REDACTED VERSION of (165 in 1:22-cv-00294-CFC, 164 in 1:22-md-03038-CFC) Notice to Take Deposition - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/23/2023) (7)
Aug 23, 2023 171 REDACTED VERSION of (164 in 1:22-cv-00294-CFC, 163 in 1:22-md-03038-CFC) Notice to Take Deposition - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 08/23/2023) (6)
Aug 22, 2023 168 NOTICE OF SERVICE of Defendants' Final Election of Asserted Prior Art filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/22/2023) (2)
Aug 17, 2023 162 [SEALED] NOTICE to Take Deposition of Mylan Pharmaceuticals Inc. on September 11, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/17/2023) (0)
Aug 17, 2023 163 [SEALED] NOTICE to Take Deposition of Rio Biopharmaceuticals Inc. and EMS S/A on September 14, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/17/2023) (0)
Aug 17, 2023 164 [SEALED] NOTICE to Take Deposition of Alvogen, Inc. on September 18, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/17/2023) (0)
Aug 17, 2023 165 [SEALED] NOTICE to Take Deposition of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited on September 21, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/17/2023) (0)
Aug 17, 2023 166 [SEALED] NOTICE to Take Deposition of Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc. on September 25, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/17/2023) (0)
Aug 17, 2023 167 [SEALED] NOTICE to Take Deposition of Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. on September 28, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/17/2023) (0)
Aug 16, 2023 161 OBJECTIONS by Novo Nordisk A/S, Novo Nordisk Inc. -- Plaintiffs' Answer to Mylan Pharmaceuticals Inc.'s First Amended Counterclaims to First Amended Complaint -- (linked to 117 in 1:22-cv-01040-CFC; 154 in 1:22-md-03038-CFC). (Murray, Travis) (Entered: 08/16/2023) (30)
Aug 11, 2023 160 NOTICE OF SERVICE of (1) Defendant Mylan Pharmaceuticals Inc.s Supplemental Initial Disclosures Pursuant to the Delaware Default Standard for Discovery and (2) Mylan Pharmaceuticals Inc.s Supplemental Initial Disclosures Under Fed. R. Civ. P. 26(a)(1) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/11/2023) (2)
Aug 8, 2023 157 ORDER re (156 in 1:22-md-03038-CFC) Letter. Setting Deadlines/Hearings: Expert Witness List due by 10/20/2023. Joint Claim Construction Brief due by 11/20/2023. A Markman Hearing is set for 12/4/2023 at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 8/8/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC (kmd) (Entered: 08/08/2023) (2)
Aug 8, 2023 158 NOTICE OF SERVICE of DRL's First Amended Noninfringement Contentions regarding the 462 Patent (CONFIDENTIAL) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 08/08/2023) (2)
Aug 8, 2023 159 NOTICE to Take Deposition of Corporate 30(b)(6) Designee filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/08/2023) (18)
Aug 4, 2023 156 Letter to The Honorable Colm F. Connolly from Travis J. Murray regarding the Court's July 25, 2023 Claim Construction Order - re (113 in 1:22-cv-01040-CFC, 158 in 1:22-cv-00294-CFC, 148 in 1:22-md-03038-CFC) Order,. (Murray, Travis) (Entered: 08/04/2023) (4)
Aug 2, 2023 153 SO ORDERED, re (152 in 1:22-md-03038-CFC, 115 in 1:22-cv-01040-CFC) Stipulation to Amend Answer and Counterclaims, filed by Mylan Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 8/2/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC (kmd) (Entered: 08/02/2023) (4)
Aug 2, 2023 154 ANSWER to Amended Complaint, re: 111 Amended Complaint , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/02/2023) (30)
Aug 2, 2023 155 NOTICE OF SERVICE of Novo Nordisk's First Amended Responses to Defendants' Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,129,343; 8,536,122; 8,114,833; 8,920,383; 9,775,953; 9,457,154; and 10,335,462 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 08/02/2023) (12)
Aug 1, 2023 152 STIPULATION to Amend Answer and Counterclaims by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Stamoulis, Stamatios) (Entered: 08/01/2023) (0)
Jul 31, 2023 149 NOTICE OF SERVICE of (1) Plaintiffs' Second Amended Disclosures Under Paragraph 3 of the District of Delaware Default Standard; and (2) Plaintiffs' Third Amended Disclosures to Defendants Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 07/31/2023) (5)
Jul 31, 2023 150 NOTICE OF SERVICE of (1) Plaintiffs' Third Amended Disclosures Under Paragraph 3 of the District of Delaware Default Standard; and (2) Plaintiffs' Third Amended Disclosures to Defendants Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure (specific sets separately to Sun and Zydus defendant groups) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 07/31/2023) (6)
Jul 31, 2023 151 NOTICE OF SERVICE of (1) Plaintiffs' Second Amended Disclosures Under Paragraph 3 of the District of Delaware Default Standard; and (2) Plaintiffs' Second Amended Disclosures to Defendants Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure specific sets separately to Rio, DRL and Alvogen defendant groups) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 07/31/2023) (7)
Jul 25, 2023 148 CLAIM CONSTRUCTION ORDER re (147 in 1:22-md-03038-CFC, 157 in 1:22-cv-00294-CFC, 112 in 1:22-cv-01040-CFC) Proposed Claim Construction Order. Signed by Judge Colm F. Connolly on 7/25/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) (Entered: 07/25/2023) (8)
Jul 20, 2023 147 PROPOSED ORDER -- Claim Construction -- by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 07/20/2023) (8)
Jul 17, 2023 146 Official Transcript of Markman Hearing held on July 13, 2023 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/7/2023. Redacted Transcript Deadline set for 8/17/2023. Release of Transcript Restriction set for 10/16/2023. (nmf) (Entered: 07/17/2023) (134)
Jul 12, 2023 144 SO ORDERED, re (142 in 1:22-md-03038-CFC, 154 in 1:22-cv-00294-CFC, 107 in 1:22-cv-01040-CFC) Joint MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 7/12/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 07/12/2023) (6)
Jul 12, 2023 145 MOTION for Pro Hac Vice Appearance of Attorney Brandon M. White - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 07/12/2023) (4)
Jul 11, 2023 142 Joint MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) (Entered: 07/11/2023) (6)
Jul 11, 2023 143 NOTICE of Withdrawal of Michael R. Laing as Counsel by Mylan Pharmaceuticals Inc. (Stamoulis, Stamatios) (Entered: 07/11/2023) (2)
Jun 26, 2023 140 NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures to Defendant Mylan Pharmaceuticals Inc. Under Paragraph 3 of the District of Delaware Default Standard and (2) Plaintiffs' Second Amended Disclosures to Defendant Mylan Pharmaceuticals Inc. Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 06/26/2023) (5)
Jun 26, 2023 141 NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures to Defendant Alvogen, Inc. Under Paragraph 3 of the District of Delaware Default Standard, (2) Plaintiffs' First Amended Disclosures to Defendant Alvogen, Inc. Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (3) Plaintiffs' First Amended Disclosures to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Under Paragraph 3 of the District of Delaware Default Standard, (4) Plaintiffs' First Amended Disclosures to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (5) Plaintiffs' First Amended Disclosures to Defendants Rio Biopharmaceuticals Inc. and EMS S/A Under Paragraph 3 of the District of Delaware Default Standard, (6) Plaintiffs' First Amended Disclosures to Defendants Rio Biopharmaceuticals Inc. and EMS S/A Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (7) Plaintiffs' Second Amended Disclosures to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. Under Paragraph 3 of the District of Delaware Default Standard, (8) Plaintiffs' Second Amended Disclosures to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure, (9) Plaintiffs' Second Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Under Paragraph 3 of the District of Delaware Default Standard, and (10) Plaintiffs' Second Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 06/26/2023) (11)
Jun 23, 2023 138 STIPULATION TO EXTEND TIME Joint Stipulation Extending Deadline for Substantial Completion of Document Production to June 30, 2023 - filed by EMS S/A, Rio Biopharmaceuticals, Inc.. (Dorsney, Kenneth) (Entered: 06/23/2023) (6)
Jun 23, 2023 139 SO ORDERED, re (104 in 1:22-cv-01040-CFC, 138 in 1:22-md-03038-CFC, 151 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME Joint Stipulation Extending Deadline for Substantial Completion of Document Production to June 30, 2023, filed by Rio Biopharmaceuticals, Inc., EMS S/A. Setting Scheduling Order Deadlines: Discovery due by 6/30/2023. Signed by Judge Colm F. Connolly on 6/23/2023. Associated Cases: 1:22-cv-01040-CFC, 1:22-cv-00294-CFC, 1:22-md-03038-CFC (kmd) (Entered: 06/23/2023) (6)
Jun 8, 2023 137 REDACTED VERSION of (148 in 1:22-cv-00294-CFC, 135 in 1:22-md-03038-CFC) Stipulation - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 06/08/2023) (3)
Jun 2, 2023 136 [SEALED] SO ORDERED, re (148 in 1:22-cv-00294-CFC, 135 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '154 Patent, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 6/2/2023.This order has been emailed to local counsel. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) (Entered: 06/02/2023) (0)
Jun 1, 2023 135 [SEALED] STIPULATION and [Proposed] Order of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '154 Patent - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 06/01/2023) (0)
May 30, 2023 134 SO ORDERED, re (133 in 1:22-md-03038-CFC, 146 in 1:22-cv-00294-CFC, 102 in 1:22-cv-01040-CFC) STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to June 23, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Setting Deadlines: Discovery due by 6/23/2023. Signed by Judge Colm F. Connolly on 5/30/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 05/30/2023) (5)
May 26, 2023 133 STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to June 23, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/26/2023) (5)
May 23, 2023 132 CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/23/2023) (30)
May 19, 2023 131 STIPULATION and [Proposed] Order to Extend the Deadline to Submit Amended Joint Claim Construction Chart to and including May 23, 2023 by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/19/2023) (5)
May 16, 2023 130 REDACTED VERSION of (125 in 1:22-md-03038-CFC, 139 in 1:22-cv-00294-CFC) Stipulation of Dismissal, as to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Regarding the '154, '239, '611, '155, '063, and '363 Patents - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/16/2023) (4)
May 15, 2023 129 SO ORDERED, re (98 in 1:22-cv-01040-CFC, 141 in 1:22-cv-00294-CFC, 128 in 1:22-md-03038-CFC) STIPULATION TO EXTEND TIME to submit an amended joint claim construction chart to May 19, 2023 filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/15/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) (Entered: 05/15/2023) (4)
May 12, 2023 128 STIPULATION TO EXTEND TIME to submit an amended joint claim construction chart to May 19, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/12/2023) (4)
May 11, 2023 127 [SEALED] SO ORDERED, re (125 in 1:22-md-03038-CFC, 139 in 1:22-cv-00294-CFC) Stipulation of Dismissal As To Dr. Reddy's Laboratories, Ltd. And Dr. Reddy's Laboratories, Inc. Regarding The '154, '239, '611, '155, '063, And '363 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/11/2023.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) (Entered: 05/11/2023) (0)
May 10, 2023 125 [SEALED] STIPULATION of Dismissal As To Dr. Reddy's Laboratories, Ltd. And Dr. Reddy's Laboratories, Inc. Regarding The '154, '239, '611, '155, '063, And '363 Patents by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/10/2023) (0)
May 10, 2023 126 OBJECTIONS by Novo Nordisk A/S, Novo Nordisk Inc. to (89 in 1:22-cv-01040-CFC, 89 in 1:22-cv-01040-CFC) Answer to Amended Complaint, Counterclaim // Plaintiffs' Answer to Mylan Pharmaceuticals Inc.'s Counterclaims to First Amended Complaint. (Murray, Travis) (Entered: 05/10/2023) (30)
May 8, 2023 124 REDACTED VERSION of (137 in 1:22-cv-00294-CFC, 123 in 1:22-md-03038-CFC, 95 in 1:22-cv-01040-CFC) Appendix, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/08/2023) (Main Document) (13)
May 8, 2023 124 REDACTED VERSION of (137 in 1:22-cv-00294-CFC, 123 in 1:22-md-03038-CFC, 95 in 1:22-cv-01040-CFC) Appendix, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/08/2023) (Exs. A-L) (30)
May 8, 2023 124 REDACTED VERSION of (137 in 1:22-cv-00294-CFC, 123 in 1:22-md-03038-CFC, 95 in 1:22-cv-01040-CFC) Appendix, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/08/2023) (Exs. 1-14) (30)
May 5, 2023 123 [SEALED] Joint APPENDIX re (119 in 1:22-md-03038-CFC) Joint Claim Construction Brief, (91 in 1:22-cv-01040-CFC) Joint Claim Construction Brief, (136 in 1:22-cv-00294-CFC) Joint Claim Construction Brief - by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Exs. A-L, # 2 Exs. 1-14)(Murray, Travis) (Entered: 05/05/2023) (0)
May 2, 2023 121 STIPULATION TO EXTEND TIME for Novo Nordisk Inc. and Novo Nordisk A/S to respond to Mylan Pharmaceuticals Inc.'s Answer, Separate Defenses, and Counterclaims to First Amended Complaint to May 10, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/02/2023) (3)
May 2, 2023 122 SO ORDERED, re (93 in 1:22-cv-01040-CFC, 121 in 1:22-md-03038-CFC) STIPULATION TO EXTEND TIME for Novo Nordisk Inc. and Novo Nordisk A/S to respond to Mylan Pharmaceuticals Inc.'s Answer, Separate Defenses, and Counterclaims to First Amended Complaint to May 10, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/2/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd) (Entered: 05/02/2023) (3)
May 1, 2023 119 JOINT CLAIM CONSTRUCTION BRIEF - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Murray, Travis) (Entered: 05/01/2023) (30)
Apr 27, 2023 118 NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 04/27/2023) (2)
Apr 25, 2023 117 NOTICE OF SERVICE of Alvogen, Inc.'s First Amended and Supplemental Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Alvogen, Inc..(DiBenedetto, Emily) (Entered: 04/25/2023) (2)
Apr 12, 2023 116 ANSWER to Amended Complaint, re: 111 Amended Complaint , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 04/12/2023) (30)
Apr 6, 2023 115 NOTICE OF SERVICE of (1) Novo Nordisk's Reply Claim Construction Brief and (2) Declaration of Laura T. Moran in Support of Novo Nordisk A/S and Novo Nordisk Inc.'s Reply Claim Construction Brief - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 04/06/2023) (12)
Apr 4, 2023 114 STIPULATION TO EXTEND TIME to Respond to Amended Complaint to April 12, 2023 - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 04/04/2023) (3)
Mar 22, 2023 112 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than February 13, 2023 (as to Mylan Pharmaceuticals, Inc.'s ANDA No. 217706 added to the case in Plaintiffs' First Amended Complaint). Date of Expiration of Patent: U.S. Patent No. 8,114,833 expires on 8/13/2025; U.S. Patent Nos. 8,684,969 and 11,446,443 expire on 10/20/2025; U.S. Patent Nos. 9,108,002, 9,616,180, 9,861,757, 10,357,616, 10,376,652, and 11,311,679 expire on 1/20/2026; U.S. Patent No. 8,536,122 expires on 3/20/2026; Patent No. RE46,363 expires on 8/3/2026; U.S. Patent No. 9,687,611 expires on 2/27/2027; U.S. Patent Nos. 8,920,383, 9,775,953, 10,220,155, and 11,097,063 expire on 7/17/2026; U.S. Patent No. 9,457,154 expires on 9/27/2027; U.S. Patent No. 9,132,239 expires on 2/1/2032; U.S. Patent No. 8,129,343 expires on 12/5/2031.Thirty Month Stay Deadline: 8/13/2025. (Murray, Travis) (Entered: 03/22/2023) (2)
Mar 22, 2023 113 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,114,833; 8,129,343; 8,536,122; ;8,684,969; 8,920,383; 9,108,002; ;9,132,239; 9,457,154; 9,616,180; ;9,687,611; 9,775,953; 9,861,757; ;10,220,155; 10,335,462; 10,357,616; ;10,376,652; 11,097,063; 11,311,679; ;11,446,443; and RE46,363 . (Murray, Travis) (Entered: 03/22/2023) (2)
Mar 21, 2023 111 Amended Complaint* (1)
Dec 1, 2022 64 NOTICE OF SERVICE of Plaintiffs' First Supplemental Disclosure of Asserted Patents and Claims as to Zydus Defendants - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 12/01/2022) (3)
Nov 30, 2022 63 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s First Supplemental Objections and Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 11/30/2022) (2)
Nov 22, 2022 62 NOTICE OF SERVICE of (1) Plaintiffs' Response to Defendants' First Set of Interrogatories (Nos. 1-4); and (2) Plaintiffs' Response to Defendants' First Set of Requests for Production (Nos. 1-23) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/22/2022) (11)
Nov 21, 2022 61 REDACTED VERSION of (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) Stipulation of Dismissal by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/21/2022) (4)
Nov 18, 2022 60 NOTICE OF SERVICE of Defendants' Identification of Prior Art to Supplement Defendants' Initial Invalidity Contentions filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 11/18/2022) (2)
Nov 16, 2022 59 NOTICE OF SERVICE of Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/16/2022) (11)
Nov 15, 2022 58 [SEALED] SO ORDERED, re (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Alvogen, Inc. Regarding the '239, '611, '155, '063, and '363 Patents (Joint), filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 11/15/2022.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) Modified on 11/16/2022 (kmd). (Entered: 11/15/2022) (0)
Nov 14, 2022 57 [SEALED] STIPULATION of Dismissal as to Alvogen, Inc. Regarding the '239, '611, '155, '063, and '363 Patents (Joint) by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/14/2022) (0)
Nov 10, 2022 56 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to First Set of Collective Interrogatories (Nos. 1-12) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 11/10/2022) (2)
Nov 9, 2022 55 SO ORDERED, re (52 in 1:22-cv-01040-CFC, 52 in 1:22-md-03038-CFC) PROPOSED ORDER Adopting Scheduling Order, Protective Order and ESI Order. Signed by Judge Colm F. Connolly on 11/9/2022. (nmf) (Entered: 11/09/2022) (4)
Nov 8, 2022 53 NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and (2) Plaintiffs' First Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Under Paragraph 3 of the District of Delaware Default Standard - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/08/2022) (4)
Nov 8, 2022 54 NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures Under Paragraph 3 of the District of Delaware Default Standard to the Sun Defendants and (2) Plaintiffs' First Amended Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure to the Sun Defendants - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/08/2022) (5)
Nov 4, 2022 52 PROPOSED ORDER Adopting Scheduling Order, Protective Order and ESI Order by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) (Entered: 11/04/2022) (4)
Nov 3, 2022 51 NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-73) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 11/03/2022) (2)
Oct 27, 2022 46 NOTICE OF SERVICE of DEFENDANTS RIO BIOPHARMACEUTICALS INC. AND EMS S/AS OBJECTIONS AND RESPONSES TO PLAINTIFFS SECOND SET OF REQUESTS FOR PRODUCTION OF DOCUMENTS (NOS. 11-92) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Hitch, Cortlan) (Entered: 10/27/2022) (2)
Oct 27, 2022 47 NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 11-76) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 10/27/2022) (2)
Oct 27, 2022 48 NOTICE OF SERVICE of DRL's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-94) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 10/27/2022) (2)
Oct 27, 2022 49 NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11 - 88) filed by Alvogen, Inc..(Hoeschen, Nathan) (Entered: 10/27/2022) (2)
Oct 27, 2022 50 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 11-162) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 10/27/2022) (2)
Oct 21, 2022 45 NOTICE OF SERVICE of Defendants First Set of Interrogatories to Plaintiffs and Defendants First Set of Requests for Production to Plaintiffs filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 10/21/2022) (2)
Oct 20, 2022 36 [SEALED] SO ORDERED, re (70 in 1:22-cv-00294-CFC, 34 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '239 and '611 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 10/20/2022.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) (Entered: 10/20/2022) (0)
Oct 20, 2022 37 NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's Noninfringement Contentions Regarding Claims 12-14 of the '154 Patent filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 10/20/2022) (2)
Oct 20, 2022 38 NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Initial Noninfringement Contentions filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 10/20/2022) (2)
Oct 20, 2022 39 NOTICE OF SERVICE of copy of DRL's Noninfringement Contentions [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) (Entered: 10/20/2022) (2)
Oct 20, 2022 40 NOTICE OF SERVICE of Sun's Initial Non-Infringement Contentions filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 10/20/2022) (2)
Oct 20, 2022 41 NOTICE OF SERVICE of Alvogen, Inc.'s Preliminary Non-Infringement Contentions filed by Alvogen, Inc..(Hoeschen, Nathan) (Entered: 10/20/2022) (2)
Oct 20, 2022 42 MOTION for Pro Hac Vice Appearance of Attorney Aaron Z. Savit - filed by Alvogen, Inc.. (Hoeschen, Nathan) (Entered: 10/20/2022) (4)
Oct 20, 2022 43 NOTICE OF SERVICE of Initial Invalidity Contentions filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd..(Metzler, Sara) (Entered: 10/20/2022) (3)
Oct 20, 2022 44 NOTICE OF SERVICE of Defendants Noninfringement Contentions filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 10/20/2022) (2)
Oct 19, 2022 34 [SEALED] STIPULATION and [Proposed] Order of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '239 and '611 Patents - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/19/2022) (0)
Oct 19, 2022 35 REDACTED VERSION of (70 in 1:22-cv-00294-CFC, 34 in 1:22-md-03038-CFC) Stipulation - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/19/2022) (3)
Oct 14, 2022 33 NOTICE of Withdrawal of Joshua S. Reisberg by Alvogen, Inc. (Keller, Karen) (Entered: 10/14/2022) (2)
Oct 13, 2022 32 ANSWER to Amended Complaint, re: 25 Amended Complaint by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 10/13/2022) (27)
Oct 11, 2022 31 NOTICE OF SERVICE of Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 10/11/2022) (5)
Oct 7, 2022 26 NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 10/07/2022) (2)
Oct 7, 2022 27 NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) (Entered: 10/07/2022) (2)
Oct 7, 2022 28 NOTICE OF SERVICE of DRL's Objections and Responses to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Dr. Reddy's Laboratories Inc..(Gattuso, Dominick) (Entered: 10/07/2022) (2)
Oct 7, 2022 29 NOTICE OF SERVICE of Defendants Responses to Plaintiffs First Set of Collective Interrogatories (Nos. 1-12) filed by Alvogen, Inc..(Keller, Karen) (Entered: 10/07/2022) (2)
Oct 7, 2022 30 NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's responses to Plaintiff's First Set of Collective Interrogatories (Nos. 1-12) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 10/07/2022) (2)
Sep 29, 2022 25 Amended Complaint* (1)
Menu